Trial Profile
Research Into the Effect of SGLT2 Inhibition on Left Ventricular Remodeling in Patients With Heart Failure and Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Chronic heart failure; Heart failure; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms REFORM; The REFORM Trial
- 03 Apr 2020 Results published in the Diabetes Care
- 26 Jul 2018 New source identified and integrated. (European Clinical Trials Database; EudraCT2014-002742-42)
- 26 Jul 2018 New trial record